Generate Biomedicines: Funding, Investors & Team (Oct 2026)
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. Generate Biomedicines has proved that its machine-learning platform can generate new biological molecules with therapeutic value, accelerating the drug discovery process.
Generate Biomedicines has raised $370M across 2 funding rounds on record, the most recent an undisclosed round announced in Dec 2024.
Generate Biomedicines Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Generate Biomedicines Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Generate Biomedicines raised $370M in a Series B announced in Nov 2021.
3.1 years later, an undisclosed round was announced in Dec 2024 with no disclosed amount.
Generate Biomedicines Founders and Leadership Team
Contact details for the Generate Biomedicines team: 1 of 2 have an email address on file.
Start 14-day free trial →Generate Biomedicines Funding Compared to Other Biotechnology Startups
Funded Startups Like Generate Biomedicines in Biotechnology and Somerville
Companies Similar to Generate Biomedicines
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Generate Biomedicines Funding FAQs
What does Generate Biomedicines do?
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. Generate Biomedicines has proved that its machine-learning platform can generate new biological molecules with therapeutic value, accelerating the drug discovery process.
How much funding has Generate Biomedicines raised?
Generate Biomedicines has raised $370M across 2 rounds on record.
When did Generate Biomedicines last raise funding?
Generate Biomedicines' most recent funding round on record was announced in Dec 2024. The amount was not disclosed.
Who founded Generate Biomedicines?
FundedIQ lists Gevorg Grigoryan (Founder) at Generate Biomedicines.
Who is the CEO of Generate Biomedicines?
Michael Nally is listed as CEO at Generate Biomedicines.
Where is Generate Biomedicines headquartered?
Generate Biomedicines is based in Somerville, Massachusetts, United States.
How many employees does Generate Biomedicines have?
Generate Biomedicines is in the 251-500 employee band.
About FundedIQ's Generate Biomedicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Generate Biomedicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.